Annotations: 12ES

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Heavy chain of the Fab fragment of an anti-kappa light chain antibody REGN654	-	-	-
B	Light chain of the Fab fragment of an anti-kappa light chain antibody REGN654	-	-	-
C	Tumor necrosis factor receptor superfamily member 17	molecular transducer activity signaling receptor activity	response to stimulus immune response immune system process adaptive immune response cellular response to stimulus regulation of biological process regulation of cellular process signaling biological regulation cellular process signal transduction cell communication cell surface receptor signaling pathway response to cytokine response to stimulus immune response immune system process adaptive immune response cellular response to stimulus regulation of biological process regulation of cellular process signaling biological regulation cellular process signal transduction cell communication cell surface receptor signaling pathway response to cytokine cytokine-mediated signaling pathway response to peptide cellular response to tumor necrosis factor response to chemical tumor necrosis factor-mediated signaling pathway cellular response to cytokine stimulus response to tumor necrosis factor	cellular anatomical structure endomembrane system cell periphery plasma membrane membrane
D	Heavy chain of the BCMA-targeted Fab arm of linvoseltamab	-	-	-
E	Light chain of the BCMA-targeted Fab arm of linvoseltamab	-	-	-

Chains	Accession	Name	Type
C	IPR022320	Tumour necrosis factor receptor 17	Family
C	IPR015337	BCMA, TALL-1 binding	Domain
C	IPR043521	Tumor necrosis factor receptor 13C/17	Family

Chains	Drug Target	Associated Disease
C	: Q02223	gastric carcinoma cancer exocrine pancreatic carcinoma hepatocellular carcinoma malignant colon neoplasm osteosarcoma Relapse multiple myeloma tuberculosis cutaneous lupus erythematosus gastric cancer interstitial cystitis malignant pancreatic neoplasm periodontitis sinusitis ulcerative colitis gastric carcinoma cancer exocrine pancreatic carcinoma hepatocellular carcinoma malignant colon neoplasm osteosarcoma Relapse multiple myeloma tuberculosis cutaneous lupus erythematosus gastric cancer interstitial cystitis malignant pancreatic neoplasm periodontitis sinusitis ulcerative colitis cystic fibrosis lung cancer MALT lymphoma plasma cell myeloma Sjogren syndrome

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

12ES | pdb_000012es